PharmaCyte BiotechPMCB 
$1.53-2.55%24h
-2.55%24h
Global rank31881
Market cap$29.82M
Change 7d-22.34%
YTD Performance-30.45%
SP500 benchmarkUnderperform
P/E-6.95
P/S0
Revenue$0
Earnings-$4.32M
Dividend yield-
Main Sector
Healthcare
PharmaCyte Biotech (PMCB) Total Liabilities
PMCB Total Liabilities in 2022: $586.58K
According to PharmaCyte Biotech latest financial reports the total liabilities of PMCB is $586.58K, an decrease of -16.72% to 2022. At the end of 2022 company had $704.37K total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that PharmaCyte Biotech is responsible for during its operational activities.
PharmaCyte Biotech (PMCB) Total Liabilities History from 2023 to 2022
-
Value:-
PMCB Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $586.58K | -16.72% |
| 2022 | $704.37K | -2.82% |
| 2021 | $724.78K | -32.75% |
| 2020 | $1.08M | 784.18% |
| 2019 | $121.89K | - |
View the Top Total Liabilies Stocks
